Supplies/services

Ended Awarded Last action

Contract number
N6890821F0035
Awardee
Awarding agency
Obligated
$403,914

Award facts

Contract value 100% obligated
$403,914.14 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Camp Lejeune, NC 28547, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00012 $74,806
Supplemental Agreement for work within scope P00011 $0
Exercise an Option P00010 $0
Funding Only Action P00009 $74,806
Exercise an Option P00008 · Reagents and blood collection supplies $0
Other Administrative Action P00007 $74,806
Supplemental Agreement for work within scope P00006 $0
Exercise an Option P00005 $0
Funding Only Action P00004 $89,748
Exercise an Option P00003 $0
Funding Only Action P00002 $55,345
Change Order P00001 · Reagent supplies/services $34,403
Original award $0
Show all 13

About this award

Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and laboratory reagents, was awarded a $403,914.14 delivery order by the Defense Health Agency for the supply of reagents and blood collection supplies. The contract, issued on October 1, 2021, has a completion date of September 30, 2026, and will be performed at Camp Lejeune, North Carolina. This delivery order is structured as a firm fixed-price contract with no small business set-aside designation and is issued under the In Vitro Diagnostics, Reagents, and Test GSA Schedule (FSS-65-VII), which enables federal agencies to procure diagnostic supplies and equipment on an as-needed basis.

This award reflects Werfen's established role as a key supplier to the Defense Health Agency and broader federal healthcare system. The company maintains an extensive portfolio of federal contracts valued in the millions of dollars, including blanket purchase agreements and indefinite delivery contracts with multiple Veterans Integrated Service Networks and other federal medical agencies. The Defense Health Agency, which operates as the medical arm of the Department of Defense, utilizes such supply contracts to support clinical laboratory operations and diagnostic testing capabilities across military treatment facilities. Werfen's delivery orders under GSA Schedule vehicles like this one allow the Defense Health Agency to obtain specialized diagnostic reagents and blood collection supplies efficiently while maintaining budgetary certainty through established contract ceilings.

Quick answers

Who was awarded contract N6890821F0035?

N6890821F0035 was awarded to Werfen USA LLC by Defense Health Agency (Department of Defense) on October 1, 2021.

How much is contract N6890821F0035 worth?

The government has obligated $403,914 on N6890821F0035.

Is contract N6890821F0035 an order under another contract?

Yes. N6890821F0035 is a delivery order under V797D70110, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).

Was contract N6890821F0035 competed?

The extent of competition for N6890821F0035 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award